Nordea Investment Management AB Acquires 426 Shares of The Clorox Company (NYSE:CLX)

Nordea Investment Management AB grew its holdings in The Clorox Company (NYSE:CLXFree Report) by 4.5% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 9,977 shares of the company’s stock after acquiring an additional 426 shares during the period. Nordea Investment Management AB’s holdings in Clorox were worth $1,519,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Point72 Asset Management L.P. bought a new stake in shares of Clorox during the 4th quarter worth $144,844,000. Norges Bank bought a new stake in shares of Clorox during the 4th quarter worth $128,382,000. Parsifal Capital Management LP bought a new stake in shares of Clorox during the 4th quarter worth $128,245,000. Confluence Investment Management LLC bought a new stake in shares of Clorox during the 1st quarter worth $135,630,000. Finally, International Assets Investment Management LLC boosted its holdings in shares of Clorox by 17,658.5% during the 4th quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock worth $69,078,000 after buying an additional 481,725 shares during the period. 78.53% of the stock is owned by institutional investors.

Clorox Trading Up 0.1 %

Shares of Clorox stock opened at $134.84 on Friday. The stock has a market capitalization of $16.75 billion, a P/E ratio of 69.87, a price-to-earnings-growth ratio of 1.97 and a beta of 0.39. The company has a quick ratio of 0.53, a current ratio of 0.90 and a debt-to-equity ratio of 9.73. The company has a 50-day simple moving average of $134.78 and a 200 day simple moving average of $143.23. The Clorox Company has a 12-month low of $114.68 and a 12-month high of $169.14.

Clorox (NYSE:CLXGet Free Report) last issued its quarterly earnings data on Tuesday, April 30th. The company reported $1.71 EPS for the quarter, topping analysts’ consensus estimates of $1.33 by $0.38. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The firm had revenue of $1.81 billion for the quarter, compared to analyst estimates of $1.87 billion. During the same quarter in the prior year, the firm earned $1.51 EPS. The company’s revenue was down 5.3% on a year-over-year basis. Research analysts expect that The Clorox Company will post 5.91 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the stock. UBS Group decreased their price objective on shares of Clorox from $164.00 to $159.00 and set a “neutral” rating for the company in a report on Wednesday, May 1st. Citigroup reduced their price target on shares of Clorox from $150.00 to $145.00 and set a “neutral” rating for the company in a report on Wednesday. Deutsche Bank Aktiengesellschaft reduced their price target on shares of Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a report on Wednesday, April 17th. BNP Paribas initiated coverage on shares of Clorox in a report on Monday, June 24th. They issued an “underperform” rating and a $130.00 price target for the company. Finally, JPMorgan Chase & Co. reduced their price target on shares of Clorox from $159.00 to $158.00 and set a “neutral” rating for the company in a report on Wednesday, May 1st. Five equities research analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and an average target price of $144.67.

View Our Latest Stock Analysis on CLX

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Further Reading

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.